EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 210 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,020,000 | -59.2% | 31,071 | -60.8% | 0.00% | -66.7% |
| Q3 2016 | $2,498,000 | +8.8% | 79,214 | -3.0% | 0.00% | +50.0% |
| Q2 2016 | $2,295,000 | -2.5% | 81,625 | +26.0% | 0.00% | 0.0% |
| Q1 2016 | $2,354,000 | -5.8% | 64,772 | +3.7% | 0.00% | -33.3% |
| Q4 2015 | $2,499,000 | +14.6% | 62,456 | -18.4% | 0.00% | +50.0% |
| Q3 2015 | $2,181,000 | -6.3% | 76,561 | +8.4% | 0.00% | 0.0% |
| Q2 2015 | $2,327,000 | -16.0% | 70,626 | -26.6% | 0.00% | -33.3% |
| Q1 2015 | $2,769,000 | +6.9% | 96,273 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,591,000 | +9.8% | 95,137 | -14.0% | 0.00% | +50.0% |
| Q3 2014 | $2,359,000 | -11.0% | 110,687 | -6.3% | 0.00% | -33.3% |
| Q2 2014 | $2,652,000 | -6.2% | 118,090 | +5.6% | 0.00% | 0.0% |
| Q1 2014 | $2,826,000 | -59.0% | 111,838 | -62.7% | 0.00% | -57.1% |
| Q4 2013 | $6,897,000 | +309.3% | 299,990 | +239.2% | 0.01% | +250.0% |
| Q3 2013 | $1,685,000 | +574.0% | 88,437 | +410.8% | 0.00% | – |
| Q2 2013 | $250,000 | – | 17,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |